Clinical Trials on Laser-Induced Hyperpigmentation in New Zealand

Total 1441 results

New York State Psychiatric Institute

Completed

Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
Hunter College of City University of New York

Completed

An Innovative HIV Prevention Intervention Using Social Networking Technology

Substance Use | Sexual Risk

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Computer-delivered Psychosocial Intervention for Adolescent Substance Use Disorders

Substance-Related Disorders | Alcohol-Related Disorders | Marijuana Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?)

Substance-related Disorders

United States
University of New Mexico

Completed

Family Listening Program: Multi-Tribal Implementation and Evaluation

Substance Abuse

United States
FibroGen
AstraZeneca; Astellas Pharma Inc

Completed

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

Chemotherapy Induced Anemia

United States
Yale University

Completed

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Substance-Related Disorders

United States
Canyon Pharmaceuticals, Inc.

Terminated

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome (HIT)

Suspected Heparin-Induced Thrombocytopenia

United States
Western Michigan University
National Institute on Drug Abuse (NIDA)

Completed

Efficacy of Dual Focus Mutual Aid for Persons With Co-occurring Disorders

Mental Disorders | Substance Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
University of Arizona
Carrier Clinic

Active, not recruiting

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

Depression | Insomnia | Anxiety | Substance Abuse

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

NAS

United States
Oregon Research Institute

Recruiting

Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use (ASPIRE)

Substance Use | Mental Health Issue

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

The Association Between Loneliness and Substance Use

Loneliness | Opioid Use

United States
The Mind Research Network

Terminated

Mechanisms of Lorcaserin for Smoking Cessation

Smoking Cessation | Tobacco Use Disorder

United States
University of New Mexico
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Providing Expanded Continuous Labor Support to Pregnant Women in New Mexico With Substance Use Disorders (Project_SuM)

Pregnancy Related | Substance Use Disorders

United States
University of New Mexico
National Institute on Drug Abuse (NIDA)

Completed

Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians (CRAFT-AI)

Substance Use Disorders | Family Members

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs

Completed

GABA (Gamma Amino Butyric Acid) Medication for Tobacco

Nicotine Dependence

United States
The Mind Research Network
National Institute on Drug Abuse (NIDA)

Completed

TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence (TDCSNIC)

Nicotine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Automated Recovery Line for Medication Assisted Treatment

Substance Use Disorders | Drug Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

CBT With Disulfiram and Contingency Management

Cocaine Abuse

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Trial of Modafinil for Methamphetamine Dependence

Amphetamine Dependence

Australia
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
Rutgers, The State University of New Jersey

Completed

Management of Postpartum Preeclampsia (MOPP)

Postpartum Preeclampsia

United States
New York State Psychiatric Institute

Completed

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

Cocaine Dependence

United States
Columbia University
National Institute on Drug Abuse (NIDA)

Completed

Increasing MSM in the Continuum of Care in Kazakhstan

Substance-Related Disorders | HIV

United States, Kazakhstan
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders

Cannabis Dependence

United States
AstraZeneca
Nektar Therapeutics

Completed

A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

Opioid Induced Constipation (OIC)

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel... and other collaborators

Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal

United States
New York State Psychiatric Institute
Northwell Health

Completed

Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers

Alcohol Use Disorder

United States
New York State Psychiatric Institute

Terminated

Cannabinoids for Taxane Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

United States
Columbia University
National Institute on Drug Abuse (NIDA); New York University; Beth Israel Medical...

Completed

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results (iKnow2 Project)

Substance-related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Marijuana Smoking

United States
Yasmin Hurd

Recruiting

Cannabidiol for Opioid Addiction

Opioid Use Disorder

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Recruiting

Targeting Drug Memories With Methylphenidate

Substance Use Disorder | Cocaine Use Disorder

United States
NYU Langone Health

Recruiting

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Addiction | Cigarette Smoking | E Cig Use

United States
Yasmin Hurd

Completed

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute

Suspended

A Study of SPG Block for Opioid Withdrawal

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NT-814)

Opioid Use Disorder

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Nausea and Vomiting, Chemotherapy-Induced

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Black Church Treatment Study

Alcohol Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Pharmacotherapy for Schizophrenic Drug Users - 6

Substance-Related Disorders | Cocaine-Related Disorders | Shcizophrenia

United States
State University of New York at Buffalo

Completed

An Exercise App to Reduce Young Adults' MJ Use

Marijuana Smoking

United States
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

ED Observation for Opioid Use Disorder

Opiod Use Disorder

United States
Yale University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Treatment of Pregnant Women With OUD (SMART)

Opioid-use Disorder

United States

Clinical Trials on Laser-Induced Hyperpigmentation in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations